Doctor profile · Federal record
Dr. ARTURO BALANDRA, MD
Urology Physician (CMS: UROLOGY) · Urology Physician · BONITA SPRINGS, FL
- NPI 1982760369
- Accepts Medicare
- MIPS 99.2 / 100 · 2023
- 20 yrs in practice
- Licensed in 2 states
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
26800 S TAMIAMI TRL, SUITE 250
BONITA SPRINGS, FL 341344349
(239) 434-8565
fax (239) 434-8569 - Mailing address
-
2234 COLONIAL BLVD, ATTN: MANAGED CARE DEPT.
FORT MYERS, FL 339071412
Credentials & registration
- NPI registered
- December 2006 — 20 yrs on file
- Profile last updated
- December 11, 2014
- Year of graduation
- 2006 — 20 yrs since
- Specialty taxonomy
- 208800000X — NUCC code
- State licenses (2)
- Florida #ME109228 · Pennsylvania #MT188365
- Medicaid
- FL #003495400
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1982760369. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
11,114
Distinct HCPCS
10
Medicare allowed
$472,404
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J0897 |
Injection, denosumab, 1 mg | 6,120 | 14 | $23 | |
81003 |
Automated urinalysis test | 1,319 | 797 | $2 | |
51798 |
Ultrasound measurement of bladder capacity after voiding | 1,054 | 663 | $11 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 923 | 577 | $132 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 836 | 557 | $94 | |
J9217 |
Leuprolide acetate (for depot suspension), 7.5 mg | 295 | 35 | $170 | |
52000 |
Diagnostic exam of bladder and urethra using an endoscope | 99 | 91 | $250 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 92 | 92 | $174 | |
96402 |
Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 70 | 34 | $35 | |
96372 |
Injection of drug or substance under skin or into muscle | 65 | 15 | $15 |
In context: peer comparison
Among 3 peers in this city , average services per provider: 309. This provider delivers 36× the peer median.Open Payments
Industry payments received
All-time total
$2,770
Transactions
78
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Astellas Pharma US Inc | 9 | $381.35 | |
| Janssen Biotech, Inc. | 17 | $368.28 | |
| Axonics, Inc. | 9 | $348.60 | |
| PROCEPT BioRobotics Corporation | 4 | $182.19 | |
| Olympus America Inc. | 2 | $174.19 | |
| Sumitomo Pharma America, Inc. | 6 | $141.96 | |
| PFIZER INC. | 6 | $136.11 | |
| Endo USA, Inc. | 5 | $122.89 | |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $115.81 | |
| Teleflex LLC | 4 | $114.21 | |
| SRS Medical Systems, Inc. | 1 | $90.61 | |
| UROGEN PHARMA, INC. | 3 | $88.91 | |
| COLOPLAST CORP | 3 | $66.55 | |
| Boston Scientific Corporation | 3 | $63.84 | |
| Janssen Pharmaceuticals, Inc | 1 | $53.00 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
2,878
Patients
964
Total drug cost
$6,739,395
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Tamsulosin Hcl | Generic | 719 | 247 | $11,451 |
| Finasteride | Generic | 577 | 204 | $9,462 |
| Gemtesa (Vibegron) | Brand | 213 | 71 | $195,632 |
| Silodosin | Generic | 204 | 78 | $26,386 |
| Erleada (Apalutamide) | Brand | 199 | 24 | $3,019,320 |
| Xtandi (Enzalutamide) | Brand | 173 | 23 | $2,656,812 |
| Myrbetriq (Mirabegron) | Brand | 167 | 53 | $171,042 |
| Orgovyx (Relugolix) | Brand | 152 | 18 | $417,167 |
| Cefuroxime (Cefuroxime Axetil) | Brand | 116 | 103 | $1,641 |
| Solifenacin Succinate | Generic | 73 | 28 | $5,298 |